Neurotecnix was founded in 2016 to develop neurotechnologies for the diagnosis and treatment of neurological and neuropsychiatric disorders.

The core technology is based on decoding non-invasive brain activity yielding disease signatures and proprietary algorithms.

The scientific rationale has been published in several peer-reviewed scientific journals, tested and validated in pre-clinical and clinical settings and featured in multiple media outlets.